Oral phenytoin pharmacokinetics during omeprazole therapy
- PMID: 3689634
- PMCID: PMC1386318
- DOI: 10.1111/j.1365-2125.1987.tb03209.x
Oral phenytoin pharmacokinetics during omeprazole therapy
Abstract
1. In a double-blind crossover study 10 healthy males received either placebo or omeprazole (40 mg day-1) for 9 days, a single dose of phenytoin (300 mg) being taken on the seventh day. 2. Omeprazole significantly increased the area under the curve (0 to 72 h) of phenytoin (mean +/- s.e. mean) from 121.6 +/- 14.0 to 151.4 +/- 13.6 micrograms ml-1 h) (P less than 0.01). 3. The peak concentration, and apparent elimination half-life of phenytoin also tended to be increased though not significantly. 4. The omeprazole-phenytoin interaction observed may be clinically important because of the low therapeutic index associated with phenytoin.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources